Life Science Nanotech Startup Platypus To Launch Cell Migration Assay Next Week | GenomeWeb
Madison, Wisc.-based nanotech shop Platypus Technologies plans to launch its first cell-based assay — the Oris cell migration assay, which it claims is easier to use and more reproducible than current methods — within the week, a company official told CBA News this week.
 
Development of the assay was primarily funded by a $450,000 Phase I Small Business Innovation Research grant that the National Institutes of General Medical Sciences awarded last September.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.